Spleen size in patients with metabolic syndrome and its relation to metabolic and inflammatory parameters
Autor: | Rokaya Abd El-Aziz, Mervat Naguib, Laila A Rashed |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: | |
Zdroj: | The Egyptian Journal of Internal Medicine, Vol 30, Iss 2, Pp 78-82 (2018) |
Druh dokumentu: | article |
ISSN: | 1110-7782 2090-9098 |
DOI: | 10.4103/ejim.ejim_86_17 |
Popis: | Introduction Spleen may be enlarged in patients with metabolic syndrome (MS). Many factors that are encountered in MS were incriminated as etiology of the splenomegaly. The aim of this study was to assess spleen longitudinal diameter (SLD) in patients with MS and to investigate the possible factors affecting spleen size. Patients and methods The study included 60 patients with MS and 30 healthy controls. Assessment of full medical history, anthropometric measurements, and abdominal ultrasound to identify SLD and hepatic steatosis was carried out. Liver enzymes, lipid profile, and interleukin-10 (IL-10) were measured. Fatty liver index, which is considered a marker of nonalcoholic fatty liver disease, was calculated from serum triglyceride, BMI, waist circumference, and γ-glutamyl transferase. Results SLD was significantly higher in patients with MS than controls (123.57±13.88 vs. 101.20±5.44 mm, P |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |